A carregar...
Pazopanib in sarcomas: expanding the PALETTE
PURPOSE OF REVIEW: After failure of standard therapy, few effective treatment options exist for adult patients with metastatic sarcomas, and median survival remains dismal at approximately 1 year. Pazopanib, a multitargeted tyrosine kinase inhibitor, has recently been approved for nonadipocytic soft...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4090026/ https://ncbi.nlm.nih.gov/pubmed/23666473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e3283622d3a |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|